Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses and Other Long-Term Liabilities - Components of Accrued Expenses and Other Long-Term Liabilities (Detail)

v3.3.0.814
Accrued Expenses and Other Long-Term Liabilities - Components of Accrued Expenses and Other Long-Term Liabilities (Detail) - USD ($)
Sep. 30, 2015
Dec. 31, 2014
Accrued expenses:    
Professional fees $ 302,000 $ 837,000
Salaries, bonuses and related benefits 961,000 598,000
Accrued milestone, CNDO SO 500,000 0
Accrued severance 6,000 38,000
Ovamed manufacturing rights - short term component 1,500,000 1,000,000
Clinical Study Report 2,823,000 0
Research and development 589,000 832,000
Lease impairment 165,000 165,000
Other 291,000 213,000
Total accrued expenses 7,137,000 3,683,000
Other long-term liabilities:    
Ovamed manufacturing rights - long-term component 0 334,000
Long-term lease abandonment charge 82,000 268,000
Deferred rent 120,000 120,000
Total other long-term liabilities $ 202,000 $ 722,000